rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-11-24
|
pubmed:abstractText |
The objective was to determine the cost-effectiveness of treating anemic patients with chronic kidney disease (CKD) with erythropoiesis-stimulating agents (ESAs) to a low (9-10.9 g/dL), intermediate (11-12 g/dL), or high (> 12 g/dL) hemoglobin level target compared with a strategy of managing anemia without ESAs.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1523-6838
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1050-61
|
pubmed:meshHeading |
pubmed-meshheading:20932621-Aged,
pubmed-meshheading:20932621-Aged, 80 and over,
pubmed-meshheading:20932621-Anemia,
pubmed-meshheading:20932621-Chronic Disease,
pubmed-meshheading:20932621-Cohort Studies,
pubmed-meshheading:20932621-Cost-Benefit Analysis,
pubmed-meshheading:20932621-Decision Support Techniques,
pubmed-meshheading:20932621-Dose-Response Relationship, Drug,
pubmed-meshheading:20932621-Erythropoietin,
pubmed-meshheading:20932621-Female,
pubmed-meshheading:20932621-Hematinics,
pubmed-meshheading:20932621-Hemoglobins,
pubmed-meshheading:20932621-Humans,
pubmed-meshheading:20932621-Kidney Diseases,
pubmed-meshheading:20932621-Male,
pubmed-meshheading:20932621-Middle Aged,
pubmed-meshheading:20932621-Quality-Adjusted Life Years,
pubmed-meshheading:20932621-Renal Dialysis
|
pubmed:year |
2010
|
pubmed:articleTitle |
An economic evaluation of erythropoiesis-stimulating agents in CKD.
|
pubmed:affiliation |
Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. braden.manns@albertahealthservices.ca
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|